Did you know that through your TelstraSuper account you might already be invested in companies that are having a huge impact in these fields? And that your money might be changing lives for the better?

Enter Istesso – a London-based drug company in the field of immunometabolism. What is that exactly? Let’s break it down. 

Immunometabolism is an emerging branch of biology that studies the relationship between the body’s metabolism and the immune system. 

The field is centred around the discovery that cellular metabolism plays a direct role in influencing the immune system, and that immune cells can adapt to their environment.

Istesso have developed a pipeline of drugs that can be used to treat autoimmune conditions such as rheumatoid arthritis and multiple sclerosis, and life-threatening diseases like cancer and lung fibrosis. One drug, MBS2320, has the potential to both control the signs and symptoms of autoimmunity and address the underlying disease. 

TelstraSuper is proud to support Istesso’s drug discovery and development program, which is backed by some of the world’s leading scientists in immunometabolism.

It’s just one of the many ways your super can help make a real difference to people’s lives.

Want to talk about your TelstraSuper investments? Get in touch to receive simple and general advice about your investment options and risk profile at no additional cost to you. If you’d like to discuss your super, contact us on 1300 033 166 or by filling in our online contact form.